Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 2Phase 1 2Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 289INDUSTRY 132NIH 49NETWORK 13OTHER_GOV 2FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Lymphoid 1

Conditions

Melanoma 6Lymphoma, B-Cell 5Uveal Melanoma 4Esophageal Neoplasms 4Colorectal Neoplasms 4Recurrence 3Polycystic Ovary Syndrome 3Neoplasms, Plasma Cell 3Multiple Myeloma 3Hematologic Neoplasms 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Follicular 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Head and Neck Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Burkitt Lymphoma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1

Interventions

fludarabine 2Cyclophosphamide 2fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER_GOV × Leukemia × Clear all
NCT07120607 2025-08-13

Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia

Anhui Provincial Hospital

Phase 1 Not yet recruiting
9 enrolled
Other hematologic neoplasm

Leukemia

NCT05528887 2022-09-06

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

The Affiliated People's Hospital of Ningbo University

Phase 1 Recruiting
10 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡